2022 - Research.com Best Female Scientist Award
2022 - Research.com Best Scientist Award
2018 - Libin/AHFMR Prize in Cardiovascular Research
2005 - Member of the National Academy of Sciences
2003 - Distinguished Scientist Award, American Heart Association
1999 - Fellow of the American Academy of Arts and Sciences
1999 - Member of the National Academy of Medicine (NAM)
1991 - Robert J. and Claire Pasarow Foundation Medical Research Award
Member of the Association of American Physicians
Christine E. Seidman mainly focuses on Internal medicine, Genetics, Cardiomyopathy, Hypertrophic cardiomyopathy and Endocrinology. Her Internal medicine study combines topics from a wide range of disciplines, such as TNNT2, Gene mutation and Cardiology. Her Cardiomyopathy research includes elements of Left ventricular hypertrophy, Mutation, Myocyte, Heart disease and Dilated cardiomyopathy.
Her Dilated cardiomyopathy research incorporates elements of Titin and Allele. Her biological study spans a wide range of topics, including Proband, Sudden death, Oncology, Guideline and Fibrosis. Her study on Endocrinology also encompasses disciplines like
Her primary areas of study are Internal medicine, Genetics, Hypertrophic cardiomyopathy, Cardiomyopathy and Cardiology. The various areas that she examines in her Internal medicine study include Endocrinology and Gene mutation. Her Genetics study is mostly concerned with Gene, Locus, Missense mutation, Mutation and Genetic linkage.
Her Hypertrophic cardiomyopathy study also includes
Christine E. Seidman spends much of her time researching Hypertrophic cardiomyopathy, Internal medicine, Cell biology, Cardiomyopathy and Sarcomere. Her Hypertrophic cardiomyopathy study also includes fields such as
Her research on Cell biology also deals with topics like
Her primary scientific interests are in Cardiomyopathy, Sarcomere, Hypertrophic cardiomyopathy, Dilated cardiomyopathy and Cell biology. In her work, Gene and Valve replacement is strongly intertwined with Disease, which is a subfield of Cardiomyopathy. The concepts of her Sarcomere study are interwoven with issues in Contractility and Myosin.
Her Hypertrophic cardiomyopathy study contributes to a more complete understanding of Cardiology. Her Dilated cardiomyopathy research incorporates themes from Genetics, Precision medicine, Genetic testing, Unknown Significance and DNA sequencing. Her work carried out in the field of Cell biology brings together such families of science as Regulator and Cell division.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Contemporary Definitions and Classification of the Cardiomyopathies An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
Barry J. Maron;Jeffrey A. Towbin;Gaetano Thiene;Charles Antzelevitch.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani;Joseph A. Dearani.
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Anja A.T. Geisterfer-Lowrance;Susan Kass;Gary Tanigawa;Hans-Peter Vosberg.
Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.
Craig T. Basson;David R. Bachinsky;Robert C. Lin;Tatjana Levi.
Nature Genetics (1997)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani.
Journal of the American College of Cardiology (2011)
Congenital Heart Disease Caused by Mutations in the Transcription Factor NKX2-5
Jean Jacques Schott;D. Woodrow Benson;Craig T. Basson;William Pease.
The Genetic Basis for Cardiomyopathy: from Mutation Identification to Mechanistic Paradigms
J.G. Seidman;Christine Seidman.
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias.
The New England Journal of Medicine (2016)
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
Diane Fatkin;Calum MacRae;Takeshi Sasaki;Matthew R. Wolff.
The New England Journal of Medicine (1999)
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
Ludwig Thierfelder;Ludwig Thierfelder;Hugh Watkins;Hugh Watkins;Calum MacRae;Calum MacRae;Roger Lamas.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: